its efficiency was 100%

The Pfizer laboratory announced that trials of its coronavirus vaccine were 100% effective in adolescents aged 12 to 15. “First-line data from 2,260 adolescents demonstrated high antibody responses and 100% efficacy against # COVID19 and that the vaccine was well tolerated,” reported.